{
    "title": "India's Glenmark defends price of its COVID-19 drug favipiravir version",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8543609/Indias-Glenmark-defends-price-COVID-19-drug-favipiravir-version.html",
    "date": "2020-07-21",
    "keywords": [
        "company",
        "drug",
        "tablet",
        "price",
        "covid19",
        "treatment",
        "favipiravir",
        "bengaluru",
        "fabiflu",
        "dcgi",
        "statement",
        "comorbidity",
        "trial",
        "july",
        "pricing",
        "version",
        "tuesday",
        "regulator",
        "notice",
        "monday",
        "controller",
        "general",
        "india",
        "glenmark",
        "emergency",
        "use",
        "option",
        "httpsbitly3fhzx7h",
        "mildtomoderate",
        "russia",
        "china",
        "bangladesh",
        "effectiveness",
        "hypertension",
        "member",
        "parliament",
        "letter",
        "latestage",
        "reference",
        "none",
        "product",
        "information",
        "brand",
        "name",
        "unit",
        "avigan",
        "anuron",
        "kumar",
        "mitra",
        "editing",
        "krishna",
        "chandra",
        "eluri"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}